TrialDiabetologia2016

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes.

David Cherney et al.PubMed ↗Publisher ↗

No numbers read from the abstract.